MedTech News

Researcher finds way to diagnose people with sleep apnea while they’re awake
A researcher at Northeastern University has found a groundbreaking new way to diagnose people with sleep apnea that could open the door for mass screenings of a sleep disorder that affects millions of people.

Protein from small intestine may hold key to obesity treatment
A team of Ohio University researchers have made a groundbreaking development in the fight against obesity. In a study recently published in Obesity, the researchers highlight a protein that is naturally produced in the body but could potentially be applied to combat weight gain and improve metabolic health in patients with obesity.

Innovative in vivo imaging offers new treatment, hope for sufferers of chronic TMJ-related pain
A groundbreaking study has uncovered new insights into the pain pathways associated with temporomandibular joint (TMJ) disorders. Using an innovative in vivo imaging tool to capture functional activity in mouse models of TMJ injury and inflammation, the discovery could pave the way for more effective treatments for the millions affected by TMJ-related facial pain.

Developing portable, blood-based device that detects colon cancer
No one looks forward to a colonoscopy. The procedure, which is used to screen for colorectal cancers, is unpleasant and costly and can lead to medical complications. But screening for the cancer is critical; colon cancer is the second leading cause of cancer-related death in the U.S., according to the National Cancer Institute.

Non-invasive sensor measures intracranial pressure more accurately, aiding early intervention
A technology developed by the Brazilian company brain4care has been shown to be able to measure absolute values of intracranial pressure (ICP) more accurately than existing non-invasive methods. This is the result of a study published in the journal npj Digital Medicine by researchers from the University of São Paulo in Brazil, the University of Cambridge in the United Kingdom, Emory University in the United States, and the company itself.

An easy-to-apply gel prevents abdominal adhesions following surgery in animal study
Surgical adhesions—common, sometimes life-threatening complications that arise after open or laparoscopic abdominal surgery—can be prevented in mice and pigs by a gel impregnated with a molecule that blocks a key signaling pathway in the formation of scar tissue.

COVID-19 discovery opens door to new treatments for chronic lung problems
University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells’ ability to repair the lungs, helping explain the lingering effects of long COVID. The findings suggest a new treatment approach for long COVID as well as other conditions, both short-term and chronic, caused by respiratory infections such as the flu.

Valcare Medical Receives FDA Approval to Initiate Early Feasibility Study for its Novel AMEND™ Trans-Septal System
HERZLIYA, Israel and WILMINGTON, Del., March 13, 2025 /PRNewswire/ — Valcare Medical Inc., a leading innovator in transcatheter-based mitral solutions, today announced the U.S. Food and Drug Administration (FDA) has approved the AMEND™ Trans-Septal System for investigational device exemption (IDE) application to commence an Early Feasibility Study (EFS).